Xiamen Nuokang Biotechnology Co., Ltd. is a leading international drug research and development company based on cabonhydrate biochemistry. Sugar chemical biology plays an important role in in vivo immunity. Nokang cooperates with Xiamen University and Michigan State University to establish a research and development center at home and abroad. The related technology is at the international first level. Nokang has achieved remarkable results in macrophage, NK cell new immunological checkpoint inhibitors, cell therapy based on chemical methods rather than genes, viral methods (CECT), and glycosylated breast cancer vaccines. The scientific advisory team includes the internationally renowned sugar chemist Xuefei Huang (Michigan state university), James Paulson (Scripps institute) and the discoverer of the breast cancer antigen MUC1 (University of Pittsburge).

Sugar chemical biology plays an important role in immunity and is an area with great prospects. As the first domestic company to develop new drugs using sugar chemical biology as a platform technology, Nuo Kangde has won the support of many sugar chemical scientists in the industry.